607 related articles for article (PubMed ID: 26453971)
1. Acute Graft-versus-Host Disease: Novel Biological Insights.
Teshima T; Reddy P; Zeiser R
Biol Blood Marrow Transplant; 2016 Jan; 22(1):11-6. PubMed ID: 26453971
[TBL] [Abstract][Full Text] [Related]
2. Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights.
Teshima T; Reddy P; Zeiser R
Biol Blood Marrow Transplant; 2016 Mar; 22(3 Suppl):S3-8. PubMed ID: 26899274
[TBL] [Abstract][Full Text] [Related]
3. [Key players in intestinal GVHD].
Hashimoto D; Teshima T
Rinsho Ketsueki; 2015 Jul; 56(7):807-14. PubMed ID: 26251143
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
Fujiwara H
Front Immunol; 2021; 12():703298. PubMed ID: 34512627
[TBL] [Abstract][Full Text] [Related]
5. Biology-driven developments in the therapy of acute graft-versus-host disease.
Zeiser R
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):236-241. PubMed ID: 30504316
[TBL] [Abstract][Full Text] [Related]
6. Decreased secretion of Paneth cell α-defensins in graft-versus-host disease.
Eriguchi Y; Nakamura K; Hashimoto D; Shimoda S; Shimono N; Akashi K; Ayabe T; Teshima T
Transpl Infect Dis; 2015 Oct; 17(5):702-6. PubMed ID: 26198302
[TBL] [Abstract][Full Text] [Related]
7. [Disruption of gut immune system caused by damage of intestinal stem cells and their niche in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.].
Hayase E; Teshima T
Clin Calcium; 2017; 27(6):829-833. PubMed ID: 28536321
[TBL] [Abstract][Full Text] [Related]
8. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.
Mohamed FA; Thangavelu G; Rhee SY; Sage PT; O'Connor RS; Rathmell JC; Blazar BR
Front Immunol; 2021; 12():757836. PubMed ID: 34712243
[TBL] [Abstract][Full Text] [Related]
9. Role of the intestinal mucosa in acute gastrointestinal GVHD.
Peled JU; Hanash AM; Jenq RR
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):119-127. PubMed ID: 27913470
[TBL] [Abstract][Full Text] [Related]
10. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
12. Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage.
Ara T; Hashimoto D
Front Immunol; 2021; 12():713631. PubMed ID: 34512636
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.
Köhler N; Zeiser R
Front Immunol; 2018; 9():3179. PubMed ID: 30705680
[TBL] [Abstract][Full Text] [Related]
14. Intestinal microbiota-related effects on graft-versus-host disease.
Shono Y; Docampo MD; Peled JU; Perobelli SM; Jenq RR
Int J Hematol; 2015 May; 101(5):428-37. PubMed ID: 25812838
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans.
Norona J; Apostolova P; Schmidt D; Ihlemann R; Reischmann N; Taylor G; Köhler N; de Heer J; Heeg S; Andrieux G; Siranosian BA; Schmitt-Graeff A; Pfeifer D; Catalano A; Frew IJ; Proietti M; Grimbacher B; Bulashevska A; Bhatt AS; Brummer T; Clauditz T; Zabelina T; Kroeger N; Blazar BR; Boerries M; Ayuk F; Zeiser R
Blood; 2020 Sep; 136(12):1442-1455. PubMed ID: 32542357
[TBL] [Abstract][Full Text] [Related]
16. Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.
Ferrara JL; Smith CM; Sheets J; Reddy P; Serody JS
J Clin Invest; 2017 Jun; 127(7):2441-2451. PubMed ID: 28581444
[TBL] [Abstract][Full Text] [Related]
17. Effect of GVHD on the gut and intestinal microflora.
Ji H; Feng S; Liu Y; Cao Y; Lou H; Li Z
Transpl Immunol; 2024 Feb; 82():101977. PubMed ID: 38184214
[TBL] [Abstract][Full Text] [Related]
18. TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation model.
Kobayashi A; Kobayashi S; Miyai K; Osawa Y; Horiuchi T; Kato S; Maekawa T; Yamamura T; Watanabe J; Sato K; Tsuda H; Kimura F
Int J Hematol; 2018 Feb; 107(2):222-229. PubMed ID: 29027124
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.
Mathewson ND; Jenq R; Mathew AV; Koenigsknecht M; Hanash A; Toubai T; Oravecz-Wilson K; Wu SR; Sun Y; Rossi C; Fujiwara H; Byun J; Shono Y; Lindemans C; Calafiore M; Schmidt TM; Honda K; Young VB; Pennathur S; van den Brink M; Reddy P
Nat Immunol; 2016 May; 17(5):505-513. PubMed ID: 26998764
[TBL] [Abstract][Full Text] [Related]
20. Resolution of acute intestinal graft-versus-host disease.
Thiagarajan S; Neurath MF; Hildner K
Semin Immunopathol; 2019 Nov; 41(6):655-664. PubMed ID: 31673757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
